04-10-2019
October 2019
Launched inaugural crowdfunding campaign
24-09-2019
September 2019
Selected to present at TechTour Italian Healthcare Venture Forum (IHVF), Trieste, Italy, 17-19 October 2019
15-05-2019
May 2019
Selected to participate in Investor Day jointly promoted by Euronext and European Innovation Council (European Commission H2020-SME 2 Program)
19-03-2019
March 2019
Named 'Top 4 Start-Up' at COSMOFARMA Start-Up Village, Bologna, Italy
20-02-2019
February 2019
Showcased for the second time at Advanced Technology & Treatment for Diabetes (ATTD), Berlin, Germany
11-12-2018
December 2018
Awarded 'Top Presenting Company’ at Tech Tour 2018 European Venture Contest (EVC) Final for the second consecutive year, Dusseldorf, Germany
10-10-2018
October 2018
Awarded 'Best Pitch’ at TechTour Italian Healthcare Venture Forum (IHVF), Bologna, Italy
10-07-2018
July 2018
Presented at New York Venture Summit 2018 as one of 40 selected start-ups worldwide
26-04-2018
April 2018
Winner, BIGBOOSTER Class of 2018, Lyon, France
20-03-2018
March 2018
Dianax featured in “Platinum Aziende e Protagonisti”.
01-02-2018
February 2018
Showcase HbA1c device for the first time at Advanced Technologies & Treatments for Diabetes (ATTD), Vienna, Austria
01-01-2018
January 2018
First clinical trials begin at San Raffaele Hospital, Milan, Italy
01-12-2017
December 2017
‘Top Presenting Company’ at Tech Tour 2017 European Venture Contest (EVC) Final, Dusseldorf, Germany
01-11-2017
November 2017
Winner at BigBooster Camp, Lyon - qualify for next round
01-10-2017
October 2017
Rank among top five start-ups at the Italian Healthcare Venture Forum, Turin, Italy
